Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Veterinary Medicine
Volume 2014, Article ID 456524, 8 pages
http://dx.doi.org/10.1155/2014/456524
Case Report

Presumptive Ischemic Brain Infarction in a Dog with Evans’ Syndrome

“Pingry” Veterinary Hospital, Via Medaglie d’Oro 5, 70126 Bari, Italy

Received 27 August 2014; Revised 4 November 2014; Accepted 4 November 2014; Published 23 November 2014

Academic Editor: Changbaig Hyun

Copyright © 2014 Angelo Pasquale Giannuzzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Terrazzano, L. Cortese, D. Piantedosi et al., “Presence of anti-platelet IgM and IgG antibodies in dogs naturally infected by Leishmania infantum,” Veterinary Immunology and Immunopathology, vol. 110, no. 3-4, pp. 331–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Wilkerson, “Principles and applications of flow cytometry and cell sorting in companion animal medicine,” Veterinary Clinics of North America: Small Animal Practice, vol. 42, no. 1, pp. 53–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. K. R. Harkin, J. A. Hicks, and M. J. Wilkerson, “Erythrocyte-bound immunoglobulin isotypes in dogs with immune-mediated hemolytic anemia: 54 cases (2001–2010),” Journal of the American Veterinary Medical Association, vol. 241, no. 2, pp. 227–232, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. J. Wilkerson, E. Davis, W. Shuman, K. Harkin, J. Cox, and B. Rush, “Isotype-specific antibodies in horses and dogs with immune-mediated hemolytic anemia,” Journal of Veterinary Internal Medicine, vol. 14, no. 2, pp. 190–196, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. K. A. Quigley, B. J. Chelack, D. M. Haines, and M. L. Jackson, “Application of a direct flow cytometric erythrocyte immunofluorescence assay in dogs with immune-mediated hemolytic anemia and comparison to the direct antiglobulin test,” Journal of Veterinary Diagnostic Investigation, vol. 13, no. 4, pp. 297–300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. H. Dircks, H.-J. Schuberth, and R. Mischke, “Underlying diseases and clinicopathologic variables of thrombocytopenic dogs with and without platelet-bound antibodies detected by use of a flow cytometric assay: 83 cases (2004–2006),” Journal of the American Veterinary Medical Association, vol. 235, no. 8, pp. 960–966, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Chabanne, C. Bonnefont, J. Bernaud, and D. Rigal, “Clinical applications of flow cytometry and cell immunophenotyping to companion animals (dog and cat),” Methods in Cell Science, vol. 22, no. 2-3, pp. 199–207, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Tomer, “Autoimmune thrombocytopenia: determination of platelet-specific autoantibodies by flow cytometry,” Pediatric Blood and Cancer, vol. 47, no. 5, pp. 697–700, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Carli, S. Tasca, M. Trotta, T. Furlanello, M. Caldin, and L. Solano-Gallego, “Detection of erythrocyte binding IgM and IgG by flow cytometry in sick dogs with Babesia canis canis or Babesia canis vogeli infection,” Veterinary Parasitology, vol. 162, no. 1-2, pp. 51–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. Proceedings of the 23th Meeting of European Society of Veterinary Clinical Pathology, Napoli, 2005.
  11. S. T. Hecht, E. A. Eelkema, and R. E. Latchaw, “Cerebral ischemia and infarction,” in MR and CT Imaging of the Head and Neck, R. E. Latchaw, Ed., Mosby Year Book, St. Louis, Miss, USA, 1991. View at Google Scholar
  12. R. D. Adams and M. L. Victor, “Cerebrovascular diseases,” in Principles of Neurology, R. D. Adams and M. L. Victor, Eds., pp. 777–873, McGraw-Hill, New York, NY, USA, 6th edition, 1997. View at Google Scholar
  13. W. B. Thomas, D. C. Sorjonen, R. O. Scheuler, and J. N. Kornegay, “Magnetic resonance imaging of brain infarction in seven dogs,” Veterinary Radiology and Ultrasound, vol. 37, no. 5, pp. 345–350, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Berg and R. J. Joseph, “Cerebellar infarcts in two dogs diagnosed with magnetic resonance imaging,” Journal of the American Animal Hospital Association, vol. 39, no. 2, pp. 203–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. F. McConnell, L. Garosi, and S. R. Platt, “Magnetic resonance imaging findings of presumed cerebellar cerebrovascular accident in twelve dogs,” Veterinary Radiology and Ultrasound, vol. 46, no. 1, pp. 1–10, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Garosi, J. F. McConnell, S. R. Platt et al., “Results of diagnostic investigations and long-term outcome of 33 dogs with brain infarction (2000–2004),” Journal of Veterinary Internal Medicine, vol. 19, no. 5, pp. 725–731, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Garosi, J. F. McConnell, S. R. Platt et al., “Clinical and topographic magnetic resonance characteristics of suspected brain infarction in 40 dogs,” Journal of Veterinary Internal Medicine, vol. 20, no. 2, pp. 311–321, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Wessmann, K. Chandler, and L. Garosi, “Ischaemic and haemorrhagic stroke in the dog,” Veterinary Journal, vol. 180, no. 3, pp. 290–303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. C. Palmer, “Pontine infarction in a dog with unilateral involvement of the trigeminal motor nucleus and pyramidal tract,” Journal of Small Animal Practice, vol. 48, no. 1, pp. 49–52, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Negrin, L. Gaitero, and S. Añor, “Presumptive caudal cerebellar artery infarct in a dog: clinical and MRI findings,” Journal of Small Animal Practice, vol. 50, no. 11, pp. 615–618, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. G. B. Cherubini, C. Rusbridge, B. P. Singh, S. Schoeniger, and P. Mahoney, “Rostral cerebellar arterial infarct in two cats,” Journal of Feline Medicine and Surgery, vol. 9, no. 3, pp. 246–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. U. M. Altay, G. C. Skerritt, M. Hilbe, F. Ehrensperger, and F. Steffen, “Feline cerebrovascular disease: clinical and histopathologic findings in 16 cats,” Journal of the American Animal Hospital Association, vol. 47, no. 2, pp. 89–97, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. S. Garosi, “Cerebrovascular disease in dogs and cats,” Veterinary Clinics of North America—Small Animal Practice, vol. 40, no. 1, pp. 65–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. D. Cappellini, “Coagulation in the pathophysiology of hemolytic anemias,” Hematology, pp. 74–78, 2007. View at Google Scholar · View at Scopus
  25. A. R. Carr, D. L. Panciera, and L. Kidd, “Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs,” Journal of Veterinary Internal Medicine, vol. 16, no. 5, pp. 504–509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. M. K. Klein, S. W. Dow, and R. A. W. Rosychuk, “Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982–1987),” Journal of the American Veterinary Medical Association, vol. 195, no. 2, pp. 246–250, 1989. View at Google Scholar · View at Scopus
  27. A. Norton and I. Roberts, “Management of Evans syndrome,” British Journal of Haematology, vol. 132, no. 2, pp. 125–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. Ş. Yilmaz, H. Ören, G. Irken, M. Türker, E. Yilmaz, and E. Ada, “Cerebral venous thrombosis in a patient with Evans syndrome: a rare association,” Annals of Hematology, vol. 84, no. 2, pp. 124–126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Michimoto, T. Okamura, K. Suzuki, T. Watari, R. Kano, and A. Hasegawa, “Thiazole orange positive platelets in a dog with Evans' syndrome,” Journal of Veterinary Medical Science, vol. 66, no. 10, pp. 1305–1306, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Goggs, A. K. Boag, and D. L. Chan, “Concurrent immune-mediated haemolytic anaemia and severe thrombocytopenia in 21 dogs,” Veterinary Record, vol. 163, no. 11, pp. 323–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. E. S. Orcutt, J. A. Lee, and D. Bianco, “Immune-mediated hemolytic anemia and severe thrombocytopenia in dogs: 12 cases (2001–2008),” Journal of Veterinary Emergency and Critical Care, vol. 20, no. 3, pp. 338–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. R. K. Fenty, A. M. Delaforcade, S. P. Shaw, and T. E. O. Toole, “Identification of hypercoagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography,” Journal of the American Veterinary Medical Association, vol. 238, no. 4, pp. 463–467, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. J. C. Scott-Moncrieff, N. G. Treadwell, S. M. McCullough, and M. B. Brooks, “Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia,” Journal of the American Animal Hospital Association, vol. 37, no. 3, pp. 220–227, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. D. J. Weiss and J. L. Brazzell, “Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia,” Journal of Veterinary Internal Medicine, vol. 20, no. 3, pp. 682–686, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. R. Carr, D. L. Panciera, and L. Kidd, “Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs,” Journal of Veterinary Internal Medicine, vol. 16, no. 5, pp. 504–509, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. T. K. Weinkle, S. A. Center, J. F. Randolph, K. L. Warner, S. C. Barr, and H. N. Erb, “Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 Cases (1993–2002),” Journal of the American Veterinary Medical Association, vol. 226, no. 11, pp. 1869–1880, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. E. Reimer, G. C. Troy, and L. D. Wamick, “Immune-mediated hemolitic anemia: 70 cases (1988–1996),” Journal of the American Animal Hospital Association, vol. 35, pp. 384–391, 1999. View at Google Scholar
  38. M. Ishihara, Y. Fujino, A. Setoguchi et al., “Evaluation of prognostic factors and establishment of a prognostic scoring system for canine primary immune-mediated hemolytic anemia,” Journal of Veterinary Medical Science, vol. 72, no. 4, pp. 465–470, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. L. R. Johnson, M. R. Lappin, and D. C. Baker, “Pulmonary thromboembolism in 29 dogs: 1985–1995,” Journal of Veterinary Internal Medicine, vol. 13, no. 4, pp. 338–345, 1999. View at Google Scholar · View at Scopus
  40. M. F. Thompson, J. C. Scott-Moncrieff, and M. B. Brooks, “Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia,” Journal of the American Animal Hospital Association, vol. 40, no. 6, pp. 446–454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. E. Ridyard, D. J. Shaw, and E. M. Milne, “Evaluation of platelet activation in canine immune-mediated haemolytic anaemia,” Journal of Small Animal Practice, vol. 51, no. 6, pp. 296–304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin, “The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease,” The Journal of the American Medical Association, vol. 293, no. 13, pp. 1653–1662, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. C. D. Reiter, X. Wang, J. E. Tanus-Santos et al., “Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease,” Nature Medicine, vol. 8, no. 12, pp. 1383–1389, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. D. S. Houston, P. Robinson, and J. M. Gerrard, “Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cells,” Blood, vol. 76, no. 5, pp. 953–958, 1990. View at Google Scholar · View at Scopus
  45. G. J. Kato and J. G. Taylor VI, “Pleiotropic effects of intravascular haemolysis on vascular homeostasis,” British Journal of Haematology, vol. 148, no. 5, pp. 690–701, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. C. R. Morris, G. J. Kato, M. Poljakovic et al., “Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease,” The Journal of the American Medical Association, vol. 294, no. 1, pp. 81–90, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. T. B. Wills, K. J. Wardrop, and K. M. Meyers, “Detection of activated platelets in canine blood by use of flow cytometry,” American Journal of Veterinary Research, vol. 67, no. 1, pp. 56–63, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Piccin, W. G. Murphy, and O. P. Smith, “Circulating microparticles: pathophysiology and clinical implications,” Blood Reviews, vol. 21, no. 3, pp. 157–171, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. E. V. Tocchetti, R. L. Flower, and J. V. Lloyd, “Assessment of in vitro-generated platelet microparticles using a modified flow cytometric strategy,” Thrombosis Research, vol. 103, no. 1, pp. 47–55, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. B. R. Lentz, “Exposure of platelet membrane phosphatidylserine regulates blood coagulation,” Progress in Lipid Research, vol. 42, no. 5, pp. 423–438, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Allan, A. R. Limbrick, P. Thomas, and M. P. Westerman, “Release of spectrin-free spicules on reoxygenation of sickled erythrocytes,” Nature, vol. 295, no. 5850, pp. 612–613, 1982. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Wun, T. Paglieroni, A. Rangaswami et al., “Platelet activation in patients with sickle cell disease,” British Journal of Haematology, vol. 100, no. 4, pp. 741–749, 1998. View at Publisher · View at Google Scholar · View at Scopus
  53. A. S. Shet, O. Aras, K. Gupta et al., “Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes,” Blood, vol. 102, no. 7, pp. 2678–2683, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Westerman, A. Pizzey, J. Hirschman et al., “Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy,” British Journal of Haematology, vol. 142, no. 1, pp. 126–135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. A. D. L. Peña, J. Fareed, I. Thethi, S. Morales-Vidal, M. J. Schneck, and D. Shafer, “Ischemic stroke in the setting of chronic immune thrombocytopenia in an elderly patient—a therapeutic dilemma,” Clinical and Applied Thrombosis/Hemostasis, vol. 18, no. 3, pp. 324–326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Thachil, T. Callaghan, and V. Martlew, “Thromboembolic events are not uncommon in patients with immune thrombocytopenia,” British Journal of Haematology, vol. 150, no. 4, pp. 496–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Panzer, L. Höcker, R. Vormittag et al., “Flow cytometric evaluation of platelet activation in chronic autoimmune thrombocytopenia,” Pediatric Blood and Cancer, vol. 47, no. 5, pp. 694–696, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Nørgaard, “Thrombosis in patients with primary chronic immune thrombocytopenia,” Thrombosis Research, vol. 130, no. 1, pp. S74–S75, 2012. View at Publisher · View at Google Scholar · View at Scopus